Galenica AG
SIX:GALE
Galenica AG
SIX:GALE
Price:
94.55
CHF
-1.2%
Market Closed
Market Cap:
CHf4.7B
Relative Value
The Relative Value of one
GALE
stock under the Base Case scenario is
116.17
CHF.
Compared to the current market price of 94.55 CHF,
Galenica AG
is
Undervalued by 19%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GALE
Relative Value
Base Case
116.17
CHF
Undervaluation 19%
Multiples Across Competitors
GALE Competitors Multiples
Galenica AG Competitors
Galenica AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Galenica AG
SIX:GALE
|
4.8B CHF | 1.1 | 26 | 15.7 | 23.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
116B USD | 0.3 | 26.7 | 18.8 | 21.1 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.4B USD | 0.2 | 42.1 | 14.8 | 18.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
67.3B USD | 0.2 | 41.5 | 14.6 | 18.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.4B USD | 0.2 | 30.9 | 14.9 | 19.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.8B AUD | 2.7 | 33.6 | 25 | 25 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY | 0.2 | 11.4 | 15.3 | 15.3 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.2B CNY | 1.4 | 16.8 | 13 | 13 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 0.7 | 21.7 | 10.5 | 14.8 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67.5B HKD | 0.1 | 8.7 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
